Global Cord Blood Net Income

Global Cord Blood (CO) currently reports a net income of $470M as of July 2022. That compares with $510M in the prior-year period — down 7.7% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Global Cord Blood's net income history and peer comparisons.

Global Cord Blood's net income decreased from $510M to $470M — a 7.7% year-over-year decrease (period ending July 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Global Cord Blood's net income of $470M is lower than the Healthcare sector average of $16B. That is roughly 97.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Global Cord Blood reported $470M in net income as of July 2022. That compares with $510M in the prior-year period — down 7.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $470M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Global Cord Blood, and consider following CO for alerts when major investors trade the stock.